{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:11:33Z","timestamp":1781694693346,"version":"3.54.5"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Frailty, disability, and polypharmacy are prevalent in nursing home (NH) residents, often co-occurring with multimorbidity. There may be a complex interplay among them in terms of outcomes such as mortality. Aims of the study were to (i) assess whether nursing home residents with polypharmacy (5\u20139 medications) or hyperpolypharmacy (\u226510 drugs), have an increased risk of death and (ii) whether any association is modified by the co-presence of frailty or disability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cohort study with longitudinal mortality data including 4,023 residents from 50 European and 7 Israeli NH facilities (mean age = 83.6 years, 73.2% female) in The Services and Health for Elderly in Long Term care (SHELTER) cohort study. Participants were evaluated with the interRAI-LongTerm Care assessment tool. Frailty was evaluated with the FRAIL-NH scale. Hazard ratio (HR) of death over 12 months was assessed with stratified Cox proportional hazards models adjusted for demographics, facilities, and cognitive status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1,042 (25.9%) participants were not on polypharmacy, 49.8% (<jats:italic>n<\/jats:italic> = 2,002) were on polypharmacy, and 24.3% (<jats:italic>n<\/jats:italic> = 979) on hyperpolypharmacy. Frailty and disability mostly increased risk of death in the study population (frailty: HR = 1.85, 95%CI 1.49\u20132.28; disability: HR = 2.10, 95%CI 1.86\u20132.47). Among non-frail participants, multimorbidity (HR = 1.34, 95%CI = 1.01\u20131.82) and hyperpolypharmacy (HR = 1.61, 95%CI = 1.09\u20132.40) were associated with higher risk of death. Among frail participants, no other factors were associated with mortality. Polypharmacy and multimorbidity were not associated with mortality after stratification for disability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Frailty and disability are the strongest predictors of death in NH residents. Multimorbidity and hyperpolypharmacy increase mortality only in people without frailty. These findings may be relevant to identify patients who could benefit from tailored deprescription.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1091246","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:35:43Z","timestamp":1675233343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Frailty modifies the effect of polypharmacy and multimorbidity on the risk of death among nursing home residents: Results from the SHELTER study"],"prefix":"10.3389","volume":"10","author":[{"given":"Maria Beatrice","family":"Zazzara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Rocco","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fialova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Corsonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Soraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Camilla","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Denkinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Liperoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cger.2017.02.002","article-title":"Frailty in older persons","volume":"33","author":"Cesari","year":"2017","journal-title":"Clin Geriat Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bone.2016.06.009","article-title":"Frailty as a predictor of fractures among community-dwelling older people: a systematic review and meta-analysis","volume":"90","author":"Kojima","year":"2016","journal-title":"Bone."},{"key":"B4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jech-2015-206978","article-title":"Frailty as a predictor of hospitalisation among community-dwelling older people: a systematic review and meta-analysis","volume":"70","author":"Kojima","year":"2016","journal-title":"J Epidemiol Commun Health."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1080\/09638288.2016.1212282","article-title":"Frailty as a predictor of disabilities among community-dwelling older people: a systematic review and meta-analysis","volume":"39","author":"Kojima","year":"2017","journal-title":"Disabil Rehabil."},{"key":"B6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/gerona\/gly110","article-title":"Frailty and multimorbidity: a systematic review and meta-analysis","volume":"74","author":"Vetrano","year":"2019","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40266-022-00940-3","article-title":"Scoping review of studies evaluating frailty and its association with medication harm","volume":"39","author":"Lam","year":"2022","journal-title":"Drugs Aging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ageing\/afx162","article-title":"Frailty index as a predictor of mortality: a systematic review and meta-analysis","volume":"47","author":"Kojima","year":"2018","journal-title":"Age Ageing."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.pmedr.2021.101589","article-title":"Explaining the association between frailty and mortality in older adults: the mediating role of lifestyle, social, psychological, cognitive, and physical factors","volume":"24","author":"de Breij","year":"2021","journal-title":"Prevent Med Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s41999-018-0124-5","article-title":"Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis","volume":"10","author":"Palmer","year":"2019","journal-title":"Eur Geriat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1519\/JPT.0000000000000097","article-title":"Frailty as a predictor of nursing home placement among community-dwelling older adults: a systematic review and meta-analysis","volume":"41","author":"Kojima","year":"2018","journal-title":"J Geriat Phys Therapy."},{"key":"B12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jamda.2015.06.025","article-title":"Prevalence of frailty in nursing homes: a systematic review and meta-analysis","volume":"16","author":"Kojima","year":"2015","journal-title":"J Am Med Direct Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14273\/unisa-2728","article-title":"The role of physical frailty independent components on increased disabilities in institutionalized older women","volume":"19","author":"Furtado","year":"2019","journal-title":"Transl Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ageing\/afy054","article-title":"Drug consumption and futile medication prescribing in the last year of life: an observational study","volume":"47","author":"Curtin","year":"2018","journal-title":"Age Ageing."},{"key":"B15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s41999-022-00664-y","article-title":"Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department","volume":"13","author":"van Dam","year":"2022","journal-title":"Eur Geriat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6963-12-5","article-title":"Assessment of nursing home residents in Europe: the services and health for elderly in long TERm care (SHELTER) study","volume":"12","author":"Onder","year":"2012","journal-title":"BMC Health Serv Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jamda.2014.12.002","article-title":"Frailty in nursing homes: the FRAIL-NH scale","volume":"16","author":"Kaehr","year":"2015","journal-title":"J Am Med Direct Assoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s40520-021-01797-z","article-title":"Relationship between frailty and drug use among nursing homes residents: results from the SHELTER study","volume":"33","author":"Villani","year":"2021","journal-title":"Aging Clin Exp Res."},{"key":"B19","doi-asserted-by":"crossref","first-page":"M546","DOI":"10.1093\/gerona\/54.11.M546","article-title":"Scaling ADLs within the MDS","volume":"54","author":"Morris","year":"1999","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jamda.2018.04.008","article-title":"Association of polypharmacy with 1-year trajectories of cognitive and physical function in nursing home residents: results from a multicenter european study","volume":"19","author":"Vetrano","year":"2018","journal-title":"J Am Med Direct Assoc."},{"key":"B21","doi-asserted-by":"crossref","first-page":"M174","DOI":"10.1093\/geronj\/49.4.M174","article-title":"MDS cognitive performance scale","volume":"49","author":"Morris","year":"1994","journal-title":"J Gerontol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ageing\/29.2.165","article-title":"Development of a minimum data set-based depression rating scale for use in nursing homes","volume":"29","author":"Burrows","year":"2000","journal-title":"Age Ageing."},{"key":"B23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/joim.12843","article-title":"Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways","volume":"285","author":"Calder\u00f3n-Larra\u00f1aga","year":"2019","journal-title":"J Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/insr.12214","article-title":"A tutorial on multilevel survival analysis: methods, models and applications","volume":"85","author":"Austin","year":"2017","journal-title":"Int Stat Rev Revue Internationale de Statistique."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/ijerph18073580","article-title":"Frailty status and polypharmacy predict all-cause mortality in community dwelling older adults in Europe","volume":"18","author":"Mid\u00e3o","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/pds.3772","article-title":"Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people","volume":"24","author":"Herr","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","article-title":"Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493737 UK Biobank participants","volume":"3","author":"Hanlon","year":"2018","journal-title":"Lancet Public Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jamda.2017.07.008","article-title":"Frailty, polypharmacy, and health outcomes in older adults: the frailty and dependence in albacete study","volume":"19","author":"Bonaga","year":"2018","journal-title":"J Am Med Direct Assoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejim.2018.06.012","article-title":"Frailty predicts short-term survival even in older adults without multimorbidity","volume":"56","author":"Zucchelli","year":"2018","journal-title":"Eur J Intern Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/CIA.S124342","article-title":"Comparing the predictive accuracy of frailty, comorbidity, and disability for mortality: a 1-year follow-up in patients hospitalized in geriatric wards","volume":"12","author":"Ritt","year":"2017","journal-title":"Clin Intervent Aging."},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40520-020-01691-0","article-title":"Physical performance measures and hospital outcomes among Italian older adults: results from the CRIME project","volume":"33","author":"Villani","year":"2021","journal-title":"Aging Clin Exp Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","article-title":"systematic review of the evidence for deprescribing interventions among older people living with frailty","volume":"21","author":"Ibrahim","year":"2021","journal-title":"BMC Geriat."},{"key":"B33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jgs.16278","article-title":"Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria","volume":"68","author":"Curtin","year":"2020","journal-title":"J Am Geriat Soc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jamda.2019.01.130","article-title":"Deprescribing in nursing home residents on polypharmacy: incidence and associated factors","volume":"20","author":"Onder","year":"2019","journal-title":"J Am Med Direct Assoc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.3390\/ijerph19063423","article-title":"Individualized medication review in older people with multimorbidity: a comparative analysis between patients living at home and in a nursing home","volume":"19","author":"Molist-Brunet","year":"2022","journal-title":"Int J Environ Res Public Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40520-018-1004-z","article-title":"Outpatient comprehensive geriatric assessment: effects on frailty and mortality in old people with multimorbidity and high health care utilization","volume":"31","author":"Mazya","year":"2019","journal-title":"Aging Clin Exp Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for community-dwelling older adults: a systematic review and meta-analysis","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12877-020-01935-8","article-title":"The impact of interventions on management of frailty in hospitalized frail older adults: a systematic review and meta-analysis","volume":"20","author":"Rezaei-Shahsavarloo","year":"2020","journal-title":"BMC Geriatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3389\/fpsyg.2020.01568","article-title":"Emotional well-being and cognitive function have robust relationship with physical frailty in institutionalized older women","volume":"11","author":"Furtado","year":"2020","journal-title":"Front Psychol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s12603-021-1694-3","article-title":"The FRAIL-NH scale: systematic review of the use, validity and adaptations for frailty screening in nursing homes","volume":"25","author":"Liau","year":"2021","journal-title":"J Nutr Health Aging."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s40200-021-00897-x","article-title":"The conceptual and practical definitions of frailty in older adults: a systematic review","volume":"20","author":"Sobhani","year":"2021","journal-title":"J Diabet Metab Disord."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1091246\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:35:47Z","timestamp":1675233347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1091246\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":41,"alternative-id":["10.3389\/fmed.2023.1091246"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1091246","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"1091246"}}